Exhibitor

Biodesix is a leader in developing and commercializing multi-omic, blood-based diagnostic tests for lung cancer. Our mission is to develop and provide innovative tests that change medical practice and improve the lives of patients. Biodesix Lung Reflex integrates genomic and proteomic biomarkers for a comprehensive picture of non-small cell lung cancer, informing rapid treatment decisions for patients in 72 hours.